Human serum albumin (HSA) is a protein found in human blood. Over the last decade, HSA has been evaluated as a promising drug carrier. However, not being magnetic, HSA cannot be used for biomedical applications such as magnetic resonance imaging (MRI) and magnetic drug targeting. Therefore, subsequent composites building on iron oxide nanoparticles that are already used clinically as MRI contrast agents are extensively studied. Recently and in this context, innovative fully hydrophilic ultra-small CAN-stabilized maghemite ((CeL n ) 3/4+ - γ -Fe 2 O 3 ) nanoparticles have been readily fabricated. The present study discusses the design, fabrication, and characterization of a dual phase hybrid core (rHSA)-shell ((CeL n ) 3/4+ - γ -Fe 2 O 3 NPs) nanosystem. Quite importantly and in contrast to widely used encapsulation strategies, rHSA NP surface-attached (CeL n ) 3/4+ - γ -Fe
Liron L Israel, Elena I Kovalenko, Anna A Boyko, Alexander M Sapozhnikov, Ina Rosenberger, J?rg Kreuter, Lorena Passoni and Jean-Paul Lellouche
Click for full article
Liron L Israel, Elena I Kovalenko, Anna A Boyko, Alexander M Sapozhnikov, Ina Rosenberger, J?rg Kreuter, Lorena Passoni and Jean-Paul Lellouche
Click for full article
No comments:
Post a Comment